142 related articles for article (PubMed ID: 2860288)
1. Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes.
Heptinstall S; White A; Williamson L; Mitchell JR
Lancet; 1985 May; 1(8437):1071-4. PubMed ID: 2860288
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro.
Groenewegen WA; Heptinstall S
J Pharm Pharmacol; 1990 Aug; 42(8):553-7. PubMed ID: 1981582
[TBL] [Abstract][Full Text] [Related]
3. A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium).
Makheja AN; Bailey JM
Prostaglandins Leukot Med; 1982 Jun; 8(6):653-60. PubMed ID: 6810384
[TBL] [Abstract][Full Text] [Related]
4. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups.
Heptinstall S; Groenewegen WA; Spangenberg P; Loesche W
J Pharm Pharmacol; 1987 Jun; 39(6):459-65. PubMed ID: 2886604
[TBL] [Abstract][Full Text] [Related]
5. Feverfew--an antithrombotic drug?
Loesche W; Mazurov AV; Voyno-Yasenetskaya TA; Groenewegen WA; Heptinstall S; Repin VS
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):181-4. PubMed ID: 2459017
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica.
Ihantola-Vormisto A; Summanen J; Kankaanranta H; Vuorela H; Asmawi ZM; Moilanen E
Planta Med; 1997 Dec; 63(6):518-24. PubMed ID: 9434603
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological activity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.): assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in-vitro.
Brown AM; Edwards CM; Davey MR; Power JB; Lowe KC
J Pharm Pharmacol; 1997 May; 49(5):558-61. PubMed ID: 9178194
[TBL] [Abstract][Full Text] [Related]
8. Effects of an extract of feverfew (Tanacetum parthenium) on arachidonic acid metabolism in human blood platelets.
Loesche W; Groenewegen WA; Krause S; Spangenberg P; Heptinstall S
Biomed Biochim Acta; 1988; 47(10-11):S241-3. PubMed ID: 3248111
[TBL] [Abstract][Full Text] [Related]
9. Sulfhydryl/disulfide-status of blood platelets--a target for pharmacological intervention?
Till U; Bergmann I; Breddin K; Heptinstall S; Lösche W; Mazurov A; Pescarmona G
Prog Clin Biol Res; 1989; 301():341-5. PubMed ID: 2678129
[No Abstract] [Full Text] [Related]
10. Inhibition of platelet function by polymorphonuclear leukocytes.
Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
[TBL] [Abstract][Full Text] [Related]
11. Platelet aggregation in patients using feverfew for migraine.
Biggs MJ; Johnson ES; Persaud NP; Ratcliffe DM
Lancet; 1982 Oct; 2(8301):776. PubMed ID: 6125851
[No Abstract] [Full Text] [Related]
12. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products.
Heptinstall S; Awang DV; Dawson BA; Kindack D; Knight DW; May J
J Pharm Pharmacol; 1992 May; 44(5):391-5. PubMed ID: 1359053
[TBL] [Abstract][Full Text] [Related]
13. Extract of feverfew inhibits prostaglandin biosynthesis.
Collier HO; Butt NM; McDonald-Gibson WJ; Saeed SA
Lancet; 1980 Oct; 2(8200):922-3. PubMed ID: 6107575
[No Abstract] [Full Text] [Related]
14. Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium).
Sur R; Martin K; Liebel F; Lyte P; Shapiro S; Southall M
Inflammopharmacology; 2009 Feb; 17(1):42-9. PubMed ID: 19112586
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components.
Sumner H; Salan U; Knight DW; Hoult JR
Biochem Pharmacol; 1992 Jun; 43(11):2313-20. PubMed ID: 1319159
[TBL] [Abstract][Full Text] [Related]
16. 5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content.
Mittra S; Datta A; Singh SK; Singh A
Acta Pharmacol Sin; 2000 Dec; 21(12):1106-14. PubMed ID: 11603284
[TBL] [Abstract][Full Text] [Related]
17. Feverfew extracts and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts.
Piela-Smith TH; Liu X
Cell Immunol; 2001 May; 209(2):89-96. PubMed ID: 11446741
[TBL] [Abstract][Full Text] [Related]
18. Feverfew extracts and parthenolide irreversibly inhibit vascular responses of the rabbit aorta.
Barsby RW; Salan U; Knight DW; Hoult JR
J Pharm Pharmacol; 1992 Sep; 44(9):737-40. PubMed ID: 1360525
[TBL] [Abstract][Full Text] [Related]
19. The active principle in feverfew.
Makheja AN; Bailey JM
Lancet; 1981 Nov; 2(8254):1054. PubMed ID: 6118512
[No Abstract] [Full Text] [Related]
20. Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts.
Asmawi MZ; Kankaanranta H; Moilanen E; Vapaatalo H
J Pharm Pharmacol; 1993 Jun; 45(6):581-4. PubMed ID: 7689650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
